These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11775062)

  • 1. Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins.
    Kontush A
    Cell Mol Neurobiol; 2001 Aug; 21(4):299-315. PubMed ID: 11775062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease.
    Kontush A
    Free Radic Biol Med; 2001 Nov; 31(9):1120-31. PubMed ID: 11677045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.
    Atwood CS; Obrenovich ME; Liu T; Chan H; Perry G; Smith MA; Martins RN
    Brain Res Brain Res Rev; 2003 Sep; 43(1):1-16. PubMed ID: 14499458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity of Cu+ for the copper-binding domain of the amyloid-β peptide of Alzheimer's disease.
    Feaga HA; Maduka RC; Foster MN; Szalai VA
    Inorg Chem; 2011 Mar; 50(5):1614-8. PubMed ID: 21280585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease.
    Arlt S; Beisiegel U; Kontush A
    Curr Opin Lipidol; 2002 Jun; 13(3):289-94. PubMed ID: 12045399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.
    Chassaing S; Collin F; Dorlet P; Gout J; Hureau C; Faller P
    Curr Top Med Chem; 2012; 12(22):2573-95. PubMed ID: 23339309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions.
    Lynch T; Cherny RA; Bush AI
    Exp Gerontol; 2000 Jul; 35(4):445-51. PubMed ID: 10959032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metals and amyloid-beta in Alzheimer's disease.
    Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
    Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity.
    Caballero AB; Terol-Ordaz L; Espargaró A; Vázquez G; Nicolás E; Sabaté R; Gamez P
    Chemistry; 2016 May; 22(21):7268-80. PubMed ID: 27071336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper and Alzheimer's Disease.
    Mathys ZK; White AR
    Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Unified View of Assessing the Pro-oxidant versus Antioxidant Nature of Amyloid Beta Conformers.
    Mitra S; Prasad P; Chakraborty S
    Chembiochem; 2018 Nov; 19(22):2360-2371. PubMed ID: 30151968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.
    Chakrabarti S; Sinha M; Thakurta IG; Banerjee P; Chattopadhyay M
    Curr Med Chem; 2013; 20(37):4648-64. PubMed ID: 23834172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of metals as therapeutic targets in Alzheimer's disease.
    Finefrock AE; Bush AI; Doraiswamy PM
    J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why nutraceuticals do not prevent or treat Alzheimer's disease.
    Fisher AE; Naughton DP
    Nutr J; 2005 Apr; 4():14. PubMed ID: 15826313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease.
    Hajieva P; Behl C
    Curr Pharm Des; 2006; 12(6):699-704. PubMed ID: 16472160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.